Authors:
Zoghbi, SS
Tamagnan, G
Fujita, M
Baldwin, RM
Al-Tikriti, MS
Amici, L
Seibyl, JP
Innis, RB
Citation: Ss. Zoghbi et al., Measurement of plasma metabolites of (S)-5-[I-123]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primates, NUCL MED BI, 28(1), 2001, pp. 91-96
Authors:
Staley, JK
Krishnan-Sarin, S
Zoghbi, S
Tamagnan, G
Fujita, M
Seibyl, JP
Maciejewski, PK
O'Malley, S
Innis, RB
Citation: Jk. Staley et al., Sex differences in [I-123]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers, SYNAPSE, 41(4), 2001, pp. 275-284
Authors:
Varrone, A
Marek, KL
Jennings, D
Innis, RB
Seibyl, JP
Citation: A. Varrone et al., [I-123]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy, MOVEMENT D, 16(6), 2001, pp. 1023-1032
Authors:
van Dyck, CH
Soares, JC
Tan, PZ
Staley, JK
Baldwin, RM
Amici, LA
Fu, X
Garg, PK
Seibyl, JP
Charney, DS
Innis, RB
Citation: Ch. Van Dyck et al., Equilibrium modeling of 5-HT2A receptors with [F-18]deuteroaltanserin and PET: Feasibility of a constant infusion paradigm, NUCL MED BI, 27(8), 2000, pp. 715-722
Authors:
Castner, SA
Al-Tikriti, MS
Baldwin, RM
Seibyl, JP
Innis, RB
Goldman-Rakic, PS
Citation: Sa. Castner et al., Behavioral changes and [I-123]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine, NEUROPSYCH, 22(1), 2000, pp. 4-13
Authors:
van Dyck, CH
Malison, RT
Seibyl, JP
Laruelle, M
Klumpp, H
Zoghbi, SS
Baldwin, RM
Innis, RB
Citation: Ch. Van Dyck et al., Age-related decline in central serotonin transporter availability with [I-123]beta-CIT SPECT, NEUROBIOL A, 21(4), 2000, pp. 497-501
Authors:
Fujita, M
Tamagnan, G
Zoghbi, SS
Al-Tikriti, MS
Baldwin, RM
Seibyl, JP
Innis, RB
Citation: M. Fujita et al., Measurement of alpha(4)beta(2) nicotinic acetylcholine receptors with [I-123]5-I-A-85380 SPECT, J NUCL MED, 41(9), 2000, pp. 1552-1560
Authors:
Varrone, A
Fujita, M
Verhoeff, NPLG
Zoghbi, SS
Baldwin, RM
Rajeevan, N
Charney, DS
Seibyl, JP
Innis, RB
Citation: A. Varrone et al., Test-retest reproducibility of extrastriatal dopamine D-2 receptor imagingwith [I-123]epidepride SPECT in humans, J NUCL MED, 41(8), 2000, pp. 1343-1351
Authors:
Fujita, M
Verhoeff, NPLG
Varrone, A
Zoghbi, SS
Baldwin, RM
Jatlow, PA
Anderson, GM
Seibyl, JP
Innis, RB
Citation: M. Fujita et al., Imaging extrastriatal dopamine D-2 receptor occupancy by endogenous dopamine in healthy humans, EUR J PHARM, 387(2), 2000, pp. 179-188
Authors:
Zubal, IG
Avery, RA
Stokking, R
Studholme, C
Corsi, M
Dey, H
Seibyl, JP
Spencer, SS
Citation: Ig. Zubal et al., Ratio-images calculated from interictal positron emission tomography and single-photon emission computed tomography for quantification of the uncoupling of brain metabolism and perfusion in epilepsy, EPILEPSIA, 41(12), 2000, pp. 1560-1566
Authors:
Anand, A
Verhoeff, P
Seneca, N
Zoghbi, SS
Seibyl, JP
Charney, DS
Innis, RB
Citation: A. Anand et al., Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients, AM J PSYCHI, 157(7), 2000, pp. 1108-1114
Authors:
Jacobsen, LK
Staley, JK
Malison, RT
Zoghbi, SS
Seibyl, JP
Kosten, TR
Innis, RB
Citation: Lk. Jacobsen et al., Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients, AM J PSYCHI, 157(7), 2000, pp. 1134-1140
Authors:
Jacobsen, LK
Staley, JK
Zoghbi, S
Seibyl, JP
Kosten, TR
Innis, RB
Gelernter, J
Citation: Lk. Jacobsen et al., Prediction of dopamine transporter binding availability by genotype: A preliminary report, AM J PSYCHI, 157(10), 2000, pp. 1700-1703
Authors:
Verhoeff, NPLG
Soares, JC
D'Souza, CD
Gil, R
Degen, K
Abi-Dargham, A
Zoghbi, SS
Fujita, M
Rajeevan, N
Seibyl, JP
Krystal, JH
van Dyck, CH
Charney, DS
Innis, RB
Citation: Nplg. Verhoeff et al., [I-123]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia, PSYCH RES-N, 91(3), 1999, pp. 163-173
Authors:
Bremner, JD
Baldwin, R
Horti, A
Staib, LH
Ng, CK
Tan, PZ
Zea-Ponce, Y
Zoghbi, S
Seibyl, JP
Soufer, R
Charney, DS
Innis, RB
Citation: Jd. Bremner et al., Quantitation of benzodiazepine receptor binding with PET [C-11]iomazenil and SPECT [I-123]iomazenil: preliminary results of a direct comparison in healthy human subjects, PSYCH RES-N, 91(2), 1999, pp. 79-91
Authors:
Fujita, M
Seibyl, JP
Verhoeff, NPLG
Ichise, M
Baldwin, RM
Zoghbi, SS
Burger, C
Staley, JK
Rajeevan, N
Charney, DS
Innis, RB
Citation: M. Fujita et al., Kinetic and equilibrium analyses of [I-123]epidepride binding to striatal and extrastriatal dopamine D-2 receptors, SYNAPSE, 34(4), 1999, pp. 290-304
Authors:
Innis, RB
Marek, KL
Sheff, K
Zoghbi, S
Castronuovo, J
Feigin, A
Seibyl, JP
Citation: Rb. Innis et al., Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [I-123]beta-CIT, MOVEMENT D, 14(3), 1999, pp. 436-442
Authors:
Avery, RA
Spencer, SS
Spanaki, MV
Corsi, M
Seibyl, JP
Zubal, IG
Citation: Ra. Avery et al., Effect of injection time on postictal SPET perfusion changes in medically refractory epilepsy, EUR J NUCL, 26(8), 1999, pp. 830-836
Authors:
Ichise, M
Fujita, M
Seibyl, JP
Verhoeff, NPLG
Baldwin, RM
Zoghbi, SS
Rajeevan, N
Charney, DS
Innis, RB
Citation: M. Ichise et al., Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D-2 receptor binding with [I-123]epidepride SPECT, J NUCL MED, 40(11), 1999, pp. 1902-1912